Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Evp, Chief Financial Officer
-
Stock Symbol
-
ACAD on Nasdaq
Mark C. Schneyer - trading volume in the past year for Acadia Pharmaceuticals Inc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
53.3K |
$896K |
$16.81 |
Nov 19, 2024 |
Direct |
|
|
| Restricted Stock Units |
9.91K |
$151K |
$15.28 |
Nov 17, 2024 |
Direct |
Common Stock |
|
| Stock Options (Right to Buy) |
80.6K |
|
|
Mar 25, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.